Meeting
2016 ASCO Annual Meeting
Use of next-generation sequencing (NGS) panels to predict recurrence in low-grade, early-stage endometrioid endometrial carcinoma.
Authors
Katherine Kurnit
The University of Texas MD Anderson Cancer Center, Houston, TX
Katherine Kurnit , Bryan Fellman , Diana L Urbauer , Gordon B. Mills , Russell Broaddus
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5580)
DOI
10.1200/JCO.2016.34.15_suppl.5580
Abstract #
5580
Poster Bd #
403
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2020 Gastrointestinal Cancers Symposium
Clinical utility of targeted next generation sequencing (NGS) to predict response to neoadjuvant therapy (NT) in rectal cancer (RC).
First Author: Kristen Carroll
Poster
2018 ASCO Annual Meeting
A 12 multigene NGS panel to characterize molecular biotypes in endometrial cancer.
First Author: Ignacio Romero
Poster
2014 ASCO Annual Meeting
Advanced or recurrent endometrial cancer (EC) and co-occurring mutations in multiple oncogenic pathways.
First Author: Alexandra Leary